Research Article
Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China
Table 2
Proportion of RMR-TB among RR-TB patients from 1998 to 2013.
| | Year | Overall percentage of RMR-TB | RMR-TB in new RR-TB case | RMR-TB in previously treated RR-TB cases | RMR-TB in male RR-TB cases | RMR-TB in female RR-TB cases | | % (CI 95%) | % (CI 95%) | %(CI 95%) | %(CI 95%) | %(CI 95%) |
| | 1998 | 18.1 (11.1–25.1) | 25.5 (13.5–37.5) | 12.3 (4.3–20.3) | 18.5 (10.1–27.0) | 17.1 (4.7–29.6) | | 2003 | 11.7 (5.2–18.2) | 17.1 (5.6–28.6) | 7.5 (0.4–14.6) | 10.4 (3.1–17.8) | 14.8 (1.4–28.2) | | 2008 | 13.3 (5.6–21.0) | 18.6 (7.0–30.2) | 6.3 (-2.1–14.7) | 14.5 (5.2–23.9) | 10.0 (-3.1–23.1) | | 2013 | 14.9 (6.8–23.0) | 18.2 (6.8–29.6) | 10.0 (-0.7–20.7) | 14.3 (4.5–24.1) | 16.0 (1.6–30.4) | | Total | 14.8 (11.1–18.5) | 20.1 (14.2–26.0) | 9.4 (5.1–13.7) | 14.7 (10.3–19.1) | 15.0 (8.2–21.7) |
|
|
RMR-TB: rifampicin mono-resistant tuberculosis; RR-TB: rifampicin resistant tuberculosis.
|
